Literature DB >> 24210877

The research of nanoparticles as gene vector for tumor gene therapy.

Nian-feng Sun1, Zhan-ao Liu1, Wen-bai Huang1, Ai-ling Tian1, San-yuan Hu2.   

Abstract

With the development of molecular biology, the application of the gene therapy becomes a tendency in the development of oncotherapy. The gene therapy has been acknowledged as the major progress of modern medicine, also a focus in the oncotherapy research. Commonly vectors of the gene therapy mainly include two categories, namely, viral vectors and nonviral vectors. Nanoparticles gene vector of various different kinds of materials, which belong to non-viral carriers. It presents excellent abilities of adsorption, concentration and protection of DNA, which can be attributed as a main reason of the adsorption and operation of nano-gene vector on exogenous genes. In this article, we mainly reviewed the recent studies of the characteristics of nanoparticles, characteristics and transport mechanism of nanoparticles as gene vector, the progress on nanoparticles as gene vector in tumor gene therapy. Nano-gene vectors, as new drug and gene carriers, present characteristics such as the controlled-release, targeting, and the improvement of bioavailability. Nanoparticles for cancer imaging and therapy have evolved rapidly during the last decade and it is expected that more and more will become clinical practise. In the near future, as a new nanometer gene delivery vector will be in medical research and treatment play a bigger role.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Gene vectors; Nanoparticles; Transfection efficiency; Tumor

Mesh:

Substances:

Year:  2013        PMID: 24210877     DOI: 10.1016/j.critrevonc.2013.10.006

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  7 in total

Review 1.  Gene therapy for radioprotection.

Authors:  W H Everett; D T Curiel
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

2.  New therapeutic strategies based on interference with telomeric DNA synthesis of tumor cells to suppress the growth of tumors.

Authors:  Zhongyan Wang; Xiuli Zhao; Yan Liu; Ting Wang; Kexin Li
Journal:  RSC Adv       Date:  2018-07-11       Impact factor: 4.036

3.  Protamine nanoparticles for improving shRNA-mediated anti-cancer effects.

Authors:  Ming Liu; Bo Feng; Yijie Shi; Chang Su; Huijuan Song; Wei Cheng; Liang Zhao
Journal:  Nanoscale Res Lett       Date:  2015-03-19       Impact factor: 4.703

Review 4.  Carbon Nanotubes as an Effective Opportunity for Cancer Diagnosis and Treatment.

Authors:  Alessandro Sanginario; Beatrice Miccoli; Danilo Demarchi
Journal:  Biosensors (Basel)       Date:  2017-02-15

5.  Preparation and Evaluation of A Novel Liposomal Nano-Formulation in Metastatic Cancer Treatment Studies.

Authors:  Fatemeh Barzegari Firouzabadi; S Hahrbanoo Oryan; Mohammad Hasan Sheikhha; Seyed Mehdi Kalantar; Ameneh Javed
Journal:  Cell J       Date:  2019-02-20       Impact factor: 2.479

Review 6.  A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA.

Authors:  Ioana Toma; Alina Silvia Porfire; Lucia Ruxandra Tefas; Ioana Berindan-Neagoe; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-07-16       Impact factor: 6.525

7.  An efficient method for in vitro gene delivery via regulation of cellular endocytosis pathway.

Authors:  Jing Luo; Caixia Li; Jianlin Chen; Gang Wang; Rong Gao; Zhongwei Gu
Journal:  Int J Nanomedicine       Date:  2015-03-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.